news & events

Trade Shows and Conferences

Upcoming Events: 

Outsourcing in Clinical Trials West Coast

February 22-23, 2016 - Burlingame, CA 


Past Events:

BIO-Europe 22nd Annual Conference

November 7-9, 2016 - Cologne, Germany
Booth # 93

World Vaccine Congress 2016-Europe

October 10-12, 2016 – Barcelona, Spain

European Society for Medical Oncology (ESMO) 2016

October 7-11, 2016 – Copenhagen, Denmark

Options IX for the Control of Influenza

August 24-28, 2016 – Chicago, IL
Booth # 520

Outsourcing in Clinical Trials New England

September 7-8, 2016 – Boston, MA
Booth # 15

American Society of Clinical Oncology (ASCO)

June 3-7, 2016 – Chicago, IL
Booth #6129

World Vaccine Congress 2016

March 29-31, 2016 – Washington, DC
Booth #37

Orphan Drugs and Rare Diseases Global Congress 2016 Europe

March 14-16, 2016 – London, UK

BioWales

March 1-2, 2016 – Cardiff, Wales

SCOPE Summit for Clinical Operations Executives

February 23-25, 2016 – Miami, FL

DPharm Europe

February 9-10, 2016 – London, UK

Outsourcing in Clinical Trials West

February 10-11, 2016 – San Mateo, CA
Booth #53

Phacilitate Washington BioLeaders Forum

January 25-27, 2016 – Washington, DC

Policy Conference, Cancer Care

January 26, 2016 – Wales

 

Press Releases

01/17/2017
Panacea Pharmaceuticals and Accelovance Initiate Ph.1 Prostate Cancer Vaccine Study

10/12/2016
Accelovance Investment Further Enhances Early Phase Oncology Services

05/25/2016
Accelovance, Inc. Continues European Expansion with Acquisition of THERAMetrics AG’s CRO Services

05/19/2016
Accelovance Selected to Advance Immunicum’s Oncology Immunotherapy Pipeline

02/11/2016
Accelovance Prepared to Meet Emerging Needs for Zika Virus Research

12/02/2015
Accelovance, Inc. Continues Geographic and Service Expansion with Acquisition of Clinquest, Inc. & BV

11/03/2015
Accelovance, Inc. and FHI 360 Enhance Service Offering Through International Strategic Alliance

10/22/2015
Accelovance and ERT Partner to Implement Cloud Based Data and Analytic Solution for Clinical Trial Clients

09/30/2015
Accelovance Continues Oncology Leadership Growth with Addition of Former Global VP, Oncology from Wyeth/Pfizer and Bayer

09/15/2015
Midwest Melanoma Partnership and Accelovance, Inc. Enhance Melanoma Research Offering Through Strategic Alliance

08/13/2015
Accelovance, Inc. to Expand Global Workforce with
Grant from Welsh Government

07/07/2015
Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial

03/25/2015
Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards “Best Contract Research Organization”

02/10/2015
Panacea Pharmaceuticals Engages Accelovance For Clinical Development Of Its Novel Nanoparticle-Based Therapeutic Cancer Vaccine

02/04/2015
Accelovance Expands Capabilities in Europe with Acquisition of Altair Clinical, Ltd.

03/06/2014
Accelovance Nominated for TWO 2014 Vaccine Industry Excellence (ViE) Awards - "Best Contract Research Organization" & "Best Clinical Trial Network and Site"

02/19/2014
Accelovance Continues Expansion with Opening of Research Triangle Park, North Carolina Office

About Accelovance

Accelovance is an award-winning, niche CRO focused primarily in oncology, vaccines, and general medicine. Accelovance operates three core service divisions: